The study provided evidence of differential alternative splicing of human leukocyte antigens (HLA)-A, HLA-C and inositol hexakisphosphate kinase 2 (IP6K2) that are associated with HBV and HCV liver cancer. This evidence concerns the gene IP6K2 and liver cancer.